Posts

AgeTech in Focus: Addressing the Global Challenges of an Aging Population

As the global population ages, the demand for medical technologies and digital health platforms tailored to older adults is rapidly increasing. At LSI Europe, a panel of experts gathered to explore this evolving sector known as AgeTech: the intersection of aging and technology. Their conversation covered everything from caregiver burden and systemic inefficiencies to early diagnostic tools, patient engagement, and how AI and robotics may reshape the future of senior care. Moderated by LSI’s Henry Peck, the session featured Gal Noyman (LionBird), Soyoung Park (VU Venture Partners), and Nicole J. Walker (multiple boards, including the Alzheimer’s Association). Together, they unpacked the macro trends and micro hurdles defining the AgeTech landscape. Originally published at: https://www.lsieuropesummit.com/news/agetech-in-focus-addressing-the-global-challenges-of-an-aging-population 

Raising Capital from Family Offices: A Playbook for Founders

Raising capital is always a challenge, but raising capital from family offices requires an entirely different playbook. That was the message from the LSI Europe ’24 panel, where entrepreneurs and investors broke down the unique advantages—and nuances—of working with family offices instead of traditional medtech venture capital. Moderated by Alexei Mlodinow, former CEO and co-founder of SIA, the conversation featured insights from Marie-Louise Little (TW Medical A/S), Tyler Wanke (Wanke Family Office), John Slump (Atraverse Medical), and Pablo Prieto (CG Health Ventures). Together, they offered a candid look at what it takes to earn trust, navigate timelines, and build relationships that can unlock transformational support for medtech companies. Visit here: https://www.flipgorilla.com/p/29362908924217101/show  

Venture Capital Due Diligence: What Happens After the Verbal “Yes”?

Post-term sheet diligence is when the real work begins. For entrepreneurs, it’s about managing momentum while under a microscope. For medtech investors, it’s about confirming the deal’s risk profile—beyond the pitch deck. “You can’t be surprised with the capital markets where they are,” said Usen. “Sometimes ‘yes’ can turn out to be a really dangerous process if you go on with the wrong partner.” Originally published at: https://www.lsieuropesummit.com/news/venture-capital-due-diligence-what-happens-after-the-verbal-yes  

Digital Health Business Models : What Investors and Innovators Want

At LSI Europe, a panel of operators and investors gathered to tackle one of the most complex and consequential challenges facing the industry: how to create, deliver, and capture value in digital health. With new technologies transforming how care is delivered, from telepresence and remote monitoring to robotics and AI, the design of digital health business models has never been more important or more difficult to define. Visit here: https://www.slideshare.net/slideshow/digital-health-business-models-what-investors-and-innovators-want-pdf/283357010

Medtech Portfolio Optimization: Why Investors Say No

In the medtech world, a “no” from an investor isn’t always what it seems. The decision to pass on a startup often comes down to more than just the technology—it’s a balancing act of risk, timing, and fit. And for the investors themselves, building a smart portfolio means getting comfortable with saying no—a lot. That’s what the panelists unpacked during Investors That Pass—a candid conversation on how venture capitalists make the tough calls regarding medtech portfolio optimization. Drawing from their personal experience, the panelists pulled back the curtain on why even the most promising companies don’t always get a “yes.” Originally published at: https://www.lsieuropesummit.com/news/medtech-portfolio-optimization-why-investors-say-no-and-what-that-really-means

AI in Diagnostics: Opportunities for Transformation

The medtech industry is brimming with AI startups promising to revolutionize healthcare—but how many of those innovations are truly transformative? A panel at LSI Europe ’24 took a clear-eyed look at what it takes to move from promise to impact. The discussion, moderated by Andrew Pieprzyk of Hologic, featured Pau Rodriguez (Methinks AI), Dror Zur (Magentiq Eye), David Zakariaie (Senseye), and Gokce Gun (We Venture Capital), each bringing a distinct vantage point to the table.  Originally published at: https://www.lsieuropesummit.com/news/ai-in-diagnostics-opportunities-for-transformation

Alternate Care Sites: A Shift Transforming Patient Care

Healthcare is undergoing a major transformation as alternate care sites become a preferred setting for a growing number of procedures. From dialysis to cardiac monitoring to orthopedic surgeries, these flexible, less acute settings are offering new advantages for patients, providers, and payors. At LSI Europe ‘24, a panel of industry leaders explored the migration of care away from traditional hospital settings and into ambulatory surgery centers (ASCs), home environments, and specialized outpatient clinics. Moderated by David Uffer, Managing Director, MedTech, Trinity Life Sciences, the discussion featured insights from: Originally published at: https://www.lsieuropesummit.com/news/alternate-care-sites-a-shift-transforming-patient-care